Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Composition & Format Active: GHK-Cu (copper peptide complex) Available strengths: 50 mg or 100 mg per vial Configuration: 10 vials per kit (total 500 mg or 1000 mg per kit) Form: blue copper lyophilized powder in sterile glass vials Key Features for Wholesale Buyers China-based factory supply with consistent batches for long-term projects High-purity blue copper peptide suitable for cosmetic and anti-aging research Bulk quantity support and OEM/private-label options on request Each kit is securely packed for export and global shipping Packaging & Ordering Standard packing: 10 vials per blister tray, multiple trays per carton Kits are packed in protective inner bags and outer export cartons Typical processing and dispatch updates are provided within about 3 business days after order confirmation For larger contracts, custom packing and labeling can be arranged via our sales team Storage & Handling Store sealed vials at 28 C , protected from light and moisture Reconstituted solutions should be handled under appropriate laboratory conditions and used promptly Related Products Glow (Blend TB-500 10 mg + BPC-157 10 mg + GHK-Cu 50 mg) cosmetic & recovery stack Blend TB-500 5 mg + BPC-157 5 mg + GHK-Cu 50 mg cosmetic & skin support kit Browse all Cosmetic & Skin Peptide Kits THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY
The supplement contained a combination of collagen peptides, acerole fruit extract, l-ascorbic acid, zinc citrate, tocopherols, and biotin
Diabetes 61(6):15731583 Suzuki T, Elias BC, Seth A, Shen L, Turner JR, Giorgianni F et al (2009) PKC regulates occludin phosphorylation and epithelial tight junction integrity
Shaking can shear the delicate peptide chains, rendering them useless
This product is supplied in an encapsulated solid format to support controlled handling, storage, and measurement within laboratory research environments
Functionalization strategies have also addressed the historical challenge of off-target effects in nanomedicine
